1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Betz, S.F. Schnuchel, A. Wang, H. Olejniczak, E.T. Meadows, R.P. Fesik, S.W. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Proc.Natl.Acad.Sci.USA PNASA6 0040 0027-8424 95 7909 7914 10.1073/pnas.95.14.7909 9653114 Solution structure of the cytohesin-1 (B2-1) Sec7 domain and its interaction with the GTPase ADP ribosylation factor 1. 1998 10.2210/pdb1bc9/pdb pdb_00001bc9 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 23388.758 CYTOHESIN-1 SEC7 DOMAIN, 1 man polymer B2-1, SEC7 HOMOLOG B2-1 no no MKNMQRNKQVAMGRKKFNMDPKKGIQFLIENDLLKNTCEDIAQFLYKGEGLNKTAIGDYLGERDEFNIQVLHAFVELHEF TDLNLVQALRQFLWSFRLPGEAQKIDRMMEAFAQRYCQCNNGVFQSTDTCYVLSFAIIMLNTSLHNPNVKDKPTVERFIA MNRGINDGGDLPEELLRNLYESIKNEPFKIPELEHHHHHH MKNMQRNKQVAMGRKKFNMDPKKGIQFLIENDLLKNTCEDIAQFLYKGEGLNKTAIGDYLGERDEFNIQVLHAFVELHEF TDLNLVQALRQFLWSFRLPGEAQKIDRMMEAFAQRYCQCNNGVFQSTDTCYVLSFAIIMLNTSLHNPNVKDKPTVERFIA MNRGINDGGDLPEELLRNLYESIKNEPFKIPELEHHHHHH A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo Escherichia Escherichia coli sample BL21 B2-1 9606 SPLEEN Homo sapiens B2-1 469008 Escherichia coli BL21(DE3) BL21 (DE3) PLASMID PET-20B database_2 pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list struct_ref_seq_dif repository Initial release Version format compliance Version format compliance Database references Derived calculations Other 1 0 1999-05-11 1 1 2008-03-24 1 2 2011-07-13 1 3 2022-02-16 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.process_site _struct_ref_seq_dif.details Y BNL 1998-05-06 REL THE STRUCTURE WAS DETERMINED USING TRIPLE-RESONANCE NMR SPECTROSCOPY ON 13C, 15N-LABELED CYTOHESIN-1 SEC7 DOMAIN. MINIMIZED AVERAGE 287 1 HNCA HN(CO)CA HN(CA)CB HN (COCA)CB HNCO HN(CA)CO HCCH-TOCSY 13C-NOESY 15N-NOESY HNHA-J 0.47 M 6.8 1 atm 305 K REFINEMENT DETAILS CAN BE FOUND IN THE JRNL CITATION. DISTANCE GEOMETRY/ SIMULATED ANNEALING 20 MM NAPI, 150 MM (NH4)2SO4, 3MM DTT, 10% D2O BRUNGER refinement X-PLOR 3.1 structure solution X-PLOR 3.1 500 Bruker DRX500 600 Bruker DRX600 750 Bruker AMX750 800 Bruker DRX800 MET 57 n 1 MET 57 A LYS 58 n 2 LYS 58 A ASN 59 n 3 ASN 59 A MET 60 n 4 MET 60 A GLN 61 n 5 GLN 61 A ARG 62 n 6 ARG 62 A ASN 63 n 7 ASN 63 A LYS 64 n 8 LYS 64 A GLN 65 n 9 GLN 65 A VAL 66 n 10 VAL 66 A ALA 67 n 11 ALA 67 A MET 68 n 12 MET 68 A GLY 69 n 13 GLY 69 A ARG 70 n 14 ARG 70 A LYS 71 n 15 LYS 71 A LYS 72 n 16 LYS 72 A PHE 73 n 17 PHE 73 A ASN 74 n 18 ASN 74 A MET 75 n 19 MET 75 A ASP 76 n 20 ASP 76 A PRO 77 n 21 PRO 77 A LYS 78 n 22 LYS 78 A LYS 79 n 23 LYS 79 A GLY 80 n 24 GLY 80 A ILE 81 n 25 ILE 81 A GLN 82 n 26 GLN 82 A PHE 83 n 27 PHE 83 A LEU 84 n 28 LEU 84 A ILE 85 n 29 ILE 85 A GLU 86 n 30 GLU 86 A ASN 87 n 31 ASN 87 A ASP 88 n 32 ASP 88 A LEU 89 n 33 LEU 89 A LEU 90 n 34 LEU 90 A LYS 91 n 35 LYS 91 A ASN 92 n 36 ASN 92 A THR 93 n 37 THR 93 A CYS 94 n 38 CYS 94 A GLU 95 n 39 GLU 95 A ASP 96 n 40 ASP 96 A ILE 97 n 41 ILE 97 A ALA 98 n 42 ALA 98 A GLN 99 n 43 GLN 99 A PHE 100 n 44 PHE 100 A LEU 101 n 45 LEU 101 A TYR 102 n 46 TYR 102 A LYS 103 n 47 LYS 103 A GLY 104 n 48 GLY 104 A GLU 105 n 49 GLU 105 A GLY 106 n 50 GLY 106 A LEU 107 n 51 LEU 107 A ASN 108 n 52 ASN 108 A LYS 109 n 53 LYS 109 A THR 110 n 54 THR 110 A ALA 111 n 55 ALA 111 A ILE 112 n 56 ILE 112 A GLY 113 n 57 GLY 113 A ASP 114 n 58 ASP 114 A TYR 115 n 59 TYR 115 A LEU 116 n 60 LEU 116 A GLY 117 n 61 GLY 117 A GLU 118 n 62 GLU 118 A ARG 119 n 63 ARG 119 A ASP 120 n 64 ASP 120 A GLU 121 n 65 GLU 121 A PHE 122 n 66 PHE 122 A ASN 123 n 67 ASN 123 A ILE 124 n 68 ILE 124 A GLN 125 n 69 GLN 125 A VAL 126 n 70 VAL 126 A LEU 127 n 71 LEU 127 A HIS 128 n 72 HIS 128 A ALA 129 n 73 ALA 129 A PHE 130 n 74 PHE 130 A VAL 131 n 75 VAL 131 A GLU 132 n 76 GLU 132 A LEU 133 n 77 LEU 133 A HIS 134 n 78 HIS 134 A GLU 135 n 79 GLU 135 A PHE 136 n 80 PHE 136 A THR 137 n 81 THR 137 A ASP 138 n 82 ASP 138 A LEU 139 n 83 LEU 139 A ASN 140 n 84 ASN 140 A LEU 141 n 85 LEU 141 A VAL 142 n 86 VAL 142 A GLN 143 n 87 GLN 143 A ALA 144 n 88 ALA 144 A LEU 145 n 89 LEU 145 A ARG 146 n 90 ARG 146 A GLN 147 n 91 GLN 147 A PHE 148 n 92 PHE 148 A LEU 149 n 93 LEU 149 A TRP 150 n 94 TRP 150 A SER 151 n 95 SER 151 A PHE 152 n 96 PHE 152 A ARG 153 n 97 ARG 153 A LEU 154 n 98 LEU 154 A PRO 155 n 99 PRO 155 A GLY 156 n 100 GLY 156 A GLU 157 n 101 GLU 157 A ALA 158 n 102 ALA 158 A GLN 159 n 103 GLN 159 A LYS 160 n 104 LYS 160 A ILE 161 n 105 ILE 161 A ASP 162 n 106 ASP 162 A ARG 163 n 107 ARG 163 A MET 164 n 108 MET 164 A MET 165 n 109 MET 165 A GLU 166 n 110 GLU 166 A ALA 167 n 111 ALA 167 A PHE 168 n 112 PHE 168 A ALA 169 n 113 ALA 169 A GLN 170 n 114 GLN 170 A ARG 171 n 115 ARG 171 A TYR 172 n 116 TYR 172 A CYS 173 n 117 CYS 173 A GLN 174 n 118 GLN 174 A CYS 175 n 119 CYS 175 A ASN 176 n 120 ASN 176 A ASN 177 n 121 ASN 177 A GLY 178 n 122 GLY 178 A VAL 179 n 123 VAL 179 A PHE 180 n 124 PHE 180 A GLN 181 n 125 GLN 181 A SER 182 n 126 SER 182 A THR 183 n 127 THR 183 A ASP 184 n 128 ASP 184 A THR 185 n 129 THR 185 A CYS 186 n 130 CYS 186 A TYR 187 n 131 TYR 187 A VAL 188 n 132 VAL 188 A LEU 189 n 133 LEU 189 A SER 190 n 134 SER 190 A PHE 191 n 135 PHE 191 A ALA 192 n 136 ALA 192 A ILE 193 n 137 ILE 193 A ILE 194 n 138 ILE 194 A MET 195 n 139 MET 195 A LEU 196 n 140 LEU 196 A ASN 197 n 141 ASN 197 A THR 198 n 142 THR 198 A SER 199 n 143 SER 199 A LEU 200 n 144 LEU 200 A HIS 201 n 145 HIS 201 A ASN 202 n 146 ASN 202 A PRO 203 n 147 PRO 203 A ASN 204 n 148 ASN 204 A VAL 205 n 149 VAL 205 A LYS 206 n 150 LYS 206 A ASP 207 n 151 ASP 207 A LYS 208 n 152 LYS 208 A PRO 209 n 153 PRO 209 A THR 210 n 154 THR 210 A VAL 211 n 155 VAL 211 A GLU 212 n 156 GLU 212 A ARG 213 n 157 ARG 213 A PHE 214 n 158 PHE 214 A ILE 215 n 159 ILE 215 A ALA 216 n 160 ALA 216 A MET 217 n 161 MET 217 A ASN 218 n 162 ASN 218 A ARG 219 n 163 ARG 219 A GLY 220 n 164 GLY 220 A ILE 221 n 165 ILE 221 A ASN 222 n 166 ASN 222 A ASP 223 n 167 ASP 223 A GLY 224 n 168 GLY 224 A GLY 225 n 169 GLY 225 A ASP 226 n 170 ASP 226 A LEU 227 n 171 LEU 227 A PRO 228 n 172 PRO 228 A GLU 229 n 173 GLU 229 A GLU 230 n 174 GLU 230 A LEU 231 n 175 LEU 231 A LEU 232 n 176 LEU 232 A ARG 233 n 177 ARG 233 A ASN 234 n 178 ASN 234 A LEU 235 n 179 LEU 235 A TYR 236 n 180 TYR 236 A GLU 237 n 181 GLU 237 A SER 238 n 182 SER 238 A ILE 239 n 183 ILE 239 A LYS 240 n 184 LYS 240 A ASN 241 n 185 ASN 241 A GLU 242 n 186 GLU 242 A PRO 243 n 187 PRO 243 A PHE 244 n 188 PHE 244 A LYS 245 n 189 LYS 245 A ILE 246 n 190 ILE 246 A PRO 247 n 191 PRO 247 A GLU 248 n 192 GLU 248 A LEU 249 n 193 LEU 249 A GLU 250 n 194 GLU 250 A HIS 251 n 195 HIS 251 A HIS 252 n 196 HIS 252 A HIS 253 n 197 HIS 253 A HIS 254 n 198 HIS 254 A HIS 255 n 199 HIS 255 A HIS 256 n 200 HIS 256 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 A A O HG1 ILE THR 194 198 1.54 1 A LYS 58 -48.69 97.15 1 A ASP 76 -170.27 140.77 1 A LYS 78 79.46 -4.13 1 A ASN 92 -71.66 -165.35 1 A GLU 95 -74.23 -74.69 1 A PHE 100 -105.42 -71.64 1 A LYS 103 -144.73 -68.35 1 A GLU 105 -108.95 50.41 1 A GLU 118 -140.97 -81.59 1 A ARG 119 177.79 -71.28 1 A ASP 120 45.44 -166.58 1 A VAL 131 -114.39 57.52 1 A GLU 132 -154.52 28.54 1 A GLU 135 42.66 73.26 1 A PHE 136 -163.16 28.55 1 A LEU 139 -88.71 -75.13 1 A ASN 140 155.99 157.35 1 A PHE 148 -161.21 26.37 1 A PHE 152 -175.88 -37.70 1 A ARG 153 74.49 127.53 1 A GLU 157 72.85 -165.37 1 A ALA 158 -47.63 106.35 1 A GLN 159 -178.33 -41.94 1 A ASN 176 -128.11 -68.69 1 A ASN 177 71.76 82.46 1 A PHE 180 -96.42 41.83 1 A GLN 181 73.16 -72.62 1 A SER 182 -150.32 -78.22 1 A THR 183 -152.87 -45.76 1 A THR 198 -49.13 -71.03 1 A HIS 201 -115.20 78.79 1 A LYS 206 -48.99 99.59 1 A ASP 207 -136.17 -56.02 1 A LYS 208 71.58 64.45 1 A ASP 226 76.93 -58.77 1 A LEU 227 63.27 122.03 1 A PRO 243 -55.01 -154.40 1 A PHE 244 70.01 152.71 1 A LYS 245 -172.69 -137.54 1 A ILE 246 -36.23 155.47 1 A PRO 247 -47.63 176.05 1 A HIS 252 52.59 71.43 1 A HIS 255 -44.41 98.43 model building X-PLOR 3.1 refinement X-PLOR 3.1 phasing X-PLOR 3.1 CYTOHESIN-1/B2-1 SEC7 DOMAIN, NMR, MINIMIZED AVERAGE STRUCTURE 1 Y N A GLN 61 A GLN 5 HELX_P A MET 75 A MET 19 1 1 15 A LYS 78 A LYS 22 HELX_P A GLU 86 A GLU 30 1 2 9 A CYS 94 A CYS 38 HELX_P A TYR 102 A TYR 46 1 3 9 A LYS 109 A LYS 53 HELX_P A TYR 115 A TYR 59 1 4 7 A GLU 121 A GLU 65 HELX_P A ALA 129 A ALA 73 1 5 9 A LEU 141 A LEU 85 HELX_P A ARG 146 A ARG 90 1 6 6 A LYS 160 A LYS 104 HELX_P A TYR 172 A TYR 116 1 7 13 A ASP 184 A ASP 128 HELX_P A LEU 200 A LEU 144 1 8 17 A VAL 211 A VAL 155 HELX_P A ILE 221 A ILE 165 1 9 11 A GLU 229 A GLU 173 HELX_P A ASN 241 A ASN 185 1 10 13 EXCHANGE FACTOR EXCHANGE FACTOR, INTEGRIN BINDING PROTEIN CYH1_HUMAN UNP 1 1 Q15438 MEEDDSYVPSDLTAEERQELENIRRRKQELLADIQRLKDEIAEVANEIENLGSTEERKNMQRNKQVAMGRKKFNMDPKKG IQFLIENDLLKNTCEDIAQFLYKGEGLNKTAIGDYLGERDEFNIQVLHAFVELHEFTDLNLVQALRQFLWSFRLPGEAQK IDRMMEAFAQRYCQCNNGVFQSTDTCYVLSFAIIMLNTSLHNPNVKDKPTVERFIAMNRGINDGGDLPEELLRNLYESIK NEPFKIPEDDGNDLTHTFFNPDREGWLLKLGGGRVKTWKRRWFILTDNCLYYFEYTTDKEPRGIIPLENLSIREVEDSKK PNCFELYIPDNKDQVIKACKTEADGRVVEGNHTVYRISAPTPEEKEEWIKCIKAAISRDPFYEMLAARKKKVSSTKRH 58 256 1BC9 58 256 Q15438 A 1 2 200 1 ASP conflict LEU 249 1BC9 A Q15438 UNP 249 193 1 ASP conflict GLU 250 1BC9 A Q15438 UNP 250 194 1 GLY conflict HIS 251 1BC9 A Q15438 UNP 251 195 1 ASN conflict HIS 252 1BC9 A Q15438 UNP 252 196 1 ASP conflict HIS 253 1BC9 A Q15438 UNP 253 197 1 LEU conflict HIS 254 1BC9 A Q15438 UNP 254 198 1 THR conflict HIS 255 1BC9 A Q15438 UNP 255 199 1 P 1